Lack of research on costs of delivering immunisation during pregnancy
- PDF / 167,080 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 110 Downloads / 149 Views
1
Lack of research on costs of delivering immunisation during pregnancy Only few studies in the academic literature report estimates of the costs of delivering maternal immunisation during pregnancy, according to a review conducted by an international research team from the UK, the US and Switzerland. The researchers performed a systematic search of the peer-reviewed academic literature to identify studies that reported the non-vaccine costs of delivering maternal immunisation during pregnancy. Only 16 studies were found that met the inclusion criteria. Most studies were from high-income countries (HICs; n = 11), and only two were studies in low-income countries (LICs). The studies covered four existing vaccines (tetanus toxoid; tetanus, diphtheria and acellular pertussis [Tdap]; influenza; and hepatitis E) as well as the hypothetical introduction of a new vaccine against group B streptococcus. Six studies reported costs for delivering vaccines as part of routine antenatal-care visits. All studies reported costs from the healthcare payer perspective. This perspective, however, "included different costs in different studies," comment the researchers. The estimated cost per dose of delivering maternal immunisation ranged from $US0.55 to $0.64 for LICs, from $1.25 to $6.55 for middle-income countries, and from $5.76 to $39.87 in HICs (2018 values). The researchers note that only two studies collected primary data on resource use and costs to estimate vaccine delivery costs, and only one used a dedicated costing tool. "This highlights the need for further research to identify the economic and financial costs of delivering vaccinations during pregnancy," conclude the researchers. Procter SR, et al. A review of the costs of delivering maternal immunisation during pregnancy. Vaccine : Aug 2020. Available from: URL: http://doi.org/10.1016/ j.vaccine.2020.07.050
1173-5503/20/0860-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
803497407
PharmacoEconomics & Outcomes News 22 Aug 2020 No. 860
Data Loading...